Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer.

Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer.

Item
http://www.wikidata.org/entity/Q40427743
Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environmentCCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouseInhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude miceIntratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors.Nonreceptor tyrosine kinases in prostate cancer.Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.Zoledronic acid: an unending tale for an antiresorptive agent.Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells.Liver protects metastatic prostate cancer from induced death by activating E-cadherin signaling.Targeting tumour microenvironment by tyrosine kinase inhibitor.
P2860

Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer.

Item
http://www.wikidata.org/entity/Q40427743
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Modulation of bone microenviro ...... asis of human prostate cancer.
@en
type
label
Modulation of bone microenviro ...... asis of human prostate cancer.
@en
prefLabel
Modulation of bone microenviro ...... asis of human prostate cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Modulation of bone microenviro ...... asis of human prostate cancer.
@en
P2093
P304
P31
P356
10.1158/0008-5472.CAN-04-3601
P407
P433
P478
P577
P5875
P698